NEW YORK (GenomeWeb News) – Decode Genetics today said that its stock will be returned to the Nasdaq Global Market at the opening of trade on Monday, June 29.
The firm said that the reinstatement follows the Nasdaq Hearing and Listing Review Council's decision to reverse a February decision by the Listing Qualifications Panel to transfer Decode's stock to the Nasdaq Capital Market. Decode did not specify the reasons why its stock would be transferred back to the Global Market.
Just a few months ago, Decode's stock was in danger of being delisted from the Nasdaq Capital Market. The firm received a reprieve while the Nasdaq Listing and Hearing Review Council conducted a review and it continued to trade on that market.